These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 32298697)
1. Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy. Rodríguez-Domínguez A; Berings M; Rohrbach A; Huang HJ; Curin M; Gevaert P; Matricardi PM; Valenta R; Vrtala S J Allergy Clin Immunol; 2020 Nov; 146(5):1097-1108. PubMed ID: 32298697 [TBL] [Abstract][Full Text] [Related]
2. A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens. Huang HJ; Curin M; Banerjee S; Chen KW; Garmatiuk T; Resch-Marat Y; Carvalho-Queiroz C; Blatt K; Gafvelin G; Grönlund H; Valent P; Campana R; Focke-Tejkl M; Valenta R; Vrtala S Allergy; 2019 Dec; 74(12):2461-2478. PubMed ID: 31228873 [TBL] [Abstract][Full Text] [Related]
3. Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy. Boonpiyathad T; Sokolowska M; Morita H; Rückert B; Kast JI; Wawrzyniak M; Sangasapaviliya A; Pradubpongsa P; Fuengthong R; Thantiworasit P; Sirivichayakul S; Kwok WW; Ruxrungtham K; Akdis M; Akdis CA Allergy; 2019 May; 74(5):976-985. PubMed ID: 30485456 [TBL] [Abstract][Full Text] [Related]
4. Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy. Chen KW; Blatt K; Thomas WR; Swoboda I; Valent P; Valenta R; Vrtala S J Allergy Clin Immunol; 2012 Aug; 130(2):435-43.e4. PubMed ID: 22789398 [TBL] [Abstract][Full Text] [Related]
5. Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergens. Potapova E; Bordas-Le Floch V; Schlederer T; Vrtala S; Huang HJ; Canonica GW; Valenta R; Matricardi PM; Mascarell L Allergy; 2022 Oct; 77(10):3084-3095. PubMed ID: 35474582 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the Allergenic Potency of House Dust Extract and House Dust Mite Allergen Extract for Subcutaneous Allergen Immunotherapy. Du W; Fukano C; Yonemoto M; Matsuoka T; Masuyama K; Ohashi-Doi K Biol Pharm Bull; 2019; 42(4):601-606. PubMed ID: 30930419 [TBL] [Abstract][Full Text] [Related]
7. [Molecular allergen IgE tests show neosensitizaions occurring during house dust mite specific immunotherapy]. Long Z; Zhang Q; Zou Z; Zheng Y; Chen J Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Jul; 38(7):572-577. PubMed ID: 38973033 [No Abstract] [Full Text] [Related]
8. Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients. Chen KW; Focke-Tejkl M; Blatt K; Kneidinger M; Gieras A; Dall'Antonia F; Faé I; Fischer G; Keller W; Valent P; Valenta R; Vrtala S Allergy; 2012 May; 67(5):609-21. PubMed ID: 22339348 [TBL] [Abstract][Full Text] [Related]
9. Role of Der p 1-specific B cells in immune tolerance during 2 years of house dust mite-specific immunotherapy. Boonpiyathad T; van de Veen W; Wirz O; Sokolowska M; Rückert B; Tan G; Sangasapaviliya A; Pradubpongsa P; Fuengthong R; Thantiworasit P; Sirivichayakul S; Ruxrungtham K; Akdis CA; Akdis M J Allergy Clin Immunol; 2019 Mar; 143(3):1077-1086.e10. PubMed ID: 30529452 [TBL] [Abstract][Full Text] [Related]
10. IgE Epitopes of the House Dust Mite Allergen Der p 7 Are Mainly Discontinuous and Conformational. Curin M; Huang HJ; Garmatiuk T; Gutfreund S; Resch-Marat Y; Chen KW; Fauland K; Keller W; Zieglmayer P; Zieglmayer R; Lemell P; Horak F; Hemmer W; Focke-Tejkl M; Flicker S; Vrtala S; Valenta R Front Immunol; 2021; 12():687294. PubMed ID: 34220841 [TBL] [Abstract][Full Text] [Related]
11. Specific immunoglobulin E and immunoglobulin G4 toward major allergens of house-dust mite during allergen-specific immunotherapy. Chen J; Zhou Y; Wang Y; Zheng Y; Lai X; Westermann-Clark E; Cho SH; Kong W Am J Rhinol Allergy; 2017 May; 31(3):156-160. PubMed ID: 28490399 [TBL] [Abstract][Full Text] [Related]
12. Development of recombinant stable house dust mite allergen Der p 3 molecules for component-resolved diagnosis and specific immunotherapy. Bouaziz A; Walgraffe D; Bouillot C; Herman J; Foguenne J; Gothot A; Louis R; Hentges F; Jacquet A; Mailleux AC; Chevigné A; Galleni M; Adam E; Dumez ME Clin Exp Allergy; 2015 Apr; 45(4):823-34. PubMed ID: 25406386 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal profiles of serum specific IgE and IgG4 to Dermatophagoides pteronyssinus allergen and its major components during allergen immunotherapy in a cohort of southern Chinese children. Zeng G; Zheng P; Luo W; Huang H; Wei N; Sun B Mol Immunol; 2016 Jun; 74():1-9. PubMed ID: 27111568 [TBL] [Abstract][Full Text] [Related]
14. Identification of continuous immunoglobulin G epitopes of Dermatophagoides farinae allergens by peptide microarray immunoassay. Teng F; Han F; Zhu X; Yu L; Gai D; Xu C; Cui Y IUBMB Life; 2020 Sep; 72(9):1976-1985. PubMed ID: 32710808 [TBL] [Abstract][Full Text] [Related]
15. Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergy. Bronnert M; Mancini J; Birnbaum J; Agabriel C; Liabeuf V; Porri F; Cleach I; Fabre A; Deneux I; Grandné V; Grob JJ; Berbis P; Charpin D; Bongrand P; Vitte J Clin Exp Allergy; 2012 Sep; 42(9):1406-15). PubMed ID: 22747483 [TBL] [Abstract][Full Text] [Related]
16. The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children. Zhao D; Lai X; Tian M; Jiang Y; Zheng Y; Gjesing B; Zhong N; Spangfort MD Int Arch Allergy Immunol; 2016; 169(2):113-20. PubMed ID: 27049773 [TBL] [Abstract][Full Text] [Related]
17. Real-Life Study for the Diagnosis of House Dust Mite Allergy - The Value of Recombinant Allergen-Based IgE Serology. Becker S; Schlederer T; Kramer MF; Haack M; Vrtala S; Resch Y; Lupinek C; Valenta R; Gröger M Int Arch Allergy Immunol; 2016; 170(2):132-7. PubMed ID: 27505432 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial. Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762 [TBL] [Abstract][Full Text] [Related]
19. Similar localization of conformational IgE epitopes on the house dust mite allergens Der p 5 and Der p 21 despite limited IgE cross-reactivity. Curin M; Garmatiuk T; Resch-Marat Y; Chen KW; Hofer G; Fauland K; Keller W; Hemmer W; Vrtala S; Focke-Tejkl M; Valenta R Allergy; 2018 Aug; 73(8):1653-1661. PubMed ID: 29319884 [TBL] [Abstract][Full Text] [Related]
20. IgE recognition of the house dust mite allergen Der p 37 is associated with asthma. Huang HJ; Resch-Marat Y; Casset A; Weghofer M; Zieglmayer P; Zieglmayer R; Lemell P; Horak F; Chen KW; Potapova E; Matricardi PM; Pauli G; Grote M; Valenta R; Vrtala S J Allergy Clin Immunol; 2022 Mar; 149(3):1031-1043. PubMed ID: 34419535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]